用麦角衍生物治疗精神分裂症。
Treatment of Schizophrenia with ergot derivatives.
作者信息
Tamminga C A, Schaffer M H
出版信息
Psychopharmacology (Berl). 1979;66(3):239-42. doi: 10.1007/BF00428312.
PMID:119270
Abstract
Seven neuroleptic-free schizophrenic patients received bromocriptine and eight schizophrenic patients received CF 25-397, both ergot derivatives with dopamine agonist activity. Psychosis failed to improve in response to either drug at the relatively low doses administered. Unlike the antipsychotic property of apomorphine at low dose levels, neither of these ergot drugs improved schizophrenic symptomatology.
摘要
7名未服用抗精神病药物的精神分裂症患者接受了溴隐亭治疗，8名精神分裂症患者接受了CF 25 - 397治疗，这两种都是具有多巴胺激动剂活性的麦角衍生物。在给予相对低剂量药物时，两种药物均未能改善精神病症状。与低剂量阿扑吗啡的抗精神病特性不同，这两种麦角药物均未改善精神分裂症的症状表现。
Zotero 插件